Corporate Banner
Satellite Banner
Technology Networks Header
Thursday, October 30, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
PerkinElmer Launches Innovative Multiplexing System
Thursday, September 04, 2014
AlphaPlex™ reagent technology provides life sciences researchers with more data in less time.

Selvita Licenses Cresset’s Forge and Spark
Thursday, September 04, 2014
Computational tools for SAR analysis and ligand-based design.

Major Pharma Chooses CompacT SelecT Automated Cell Culture System
Thursday, September 04, 2014
To generate consistent, high quality cell plates for transport assays.

FEI Releases New Helios NanoLab G3 DualBeam
Thursday, September 04, 2014
Next generation DualBeam extends Helios performance leadership while enhancing usability with a new user interface and workflow-specific configurations.

FEI Announces Teneo VS for 3D Volume Imaging of Cells and Tissues
Thursday, September 04, 2014
The Teneo VS delivers excellent resolution over large volumes to allow life scientists to explore the structure and interactions of cells and tissues down to the nanometer scale.

Easy-to-use, Quantitative Gamma-H2AX Assay
Tuesday, September 02, 2014
Gamma H2AX pharmacodynamic assay kit for the study of double strand DNA breaks.

Lightweight Electronic Pipette Offers Enhanced Ease of Use
Thursday, August 28, 2014
Jump from minimum to maximum volume within a second.

Elegant Fraction Collection Storage Solution
Wednesday, August 27, 2014
Company offers a free pack of 50 cap mats with each order until 30th November 2014.

QImaging Launches New Complete, Live Cell Imaging Solution
Thursday, August 21, 2014
The package addresses live cell fluorescence imaging requirements with combined EMCCD and sCMOS camera solution.

<< 1 2 3 4 5 6 7 >>
Showing Results 31 - 40 of 2594
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv